Biohaven Ltd. sell geldnutzer
Start price
25.12.25
/
60%
€9.05
Target price
25.12.26
€7.00
Performance (%)
30.39%
End price
20.06.26
-
Summary
This prediction is currently being closed. The price for Biohaven Ltd. has massively increased, which is bad news for the SELL prediction by geldnutzer. geldnutzer has a follow-up prediction for Biohaven Ltd., but this time predicts that Biohaven Ltd. is a Buy. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biohaven Ltd. | 20.976% | 20.976% |
| iShares Core DAX® | 1,35 % | 2,74 % |
| iShares Nasdaq 100 | 3,28 % | 6,51 % |
| iShares Nikkei 225® | 7,43 % | 17,83 % |
| iShares S&P 500 | 1,70 % | 3,10 % |
According to geldnutzer what are the pros and cons of Biohaven Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Standard Investments for future growth
Capable Management
Some uniques
Future proof or reliable business model
Innovative
Good culture
Cons
Very low/no dividend yield expected
Bad rating
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Comments by geldnutzer for this prediction
In the thread Biohaven Ltd. diskutieren
In the thread Trading Biohaven Ltd.
Current prediction by geldnutzer for Biohaven Ltd.
Biohaven Ltd.
Start price
Target price
Perf. (%)
€11.80
20.06.26
20.06.26
€17.00
20.06.27
20.06.27
-
19.06.26
19.06.26
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
